Laboratory of Cancer Biology and Genetics, CCR
National Cancer Institute
United States of America
Dr. Christophe Cataisson received an M.S. diploma in cellular biology and physiology from the University Blaise Pascal, Clermont-Ferrand, France, in 1995. He then moved to the University of Jussieu, Paris, France, where he received his Ph.D. in December 2000 for his work on the regulation and function of the Parathyroid Hormone related Peptide (PTHrP) gene in human mammary cancer cells. In 2001, he joined the laboratory of Dr. Stuart Yuspa as a visiting fellow to receive his postdoctoral training. Dr. Cataisson’s integrated research takes advantage of using primary cells transformed by a single hit (oncogenic RAS) and exploring their phenotype in vivo in a relevant context.
1) Skin carcinogenesis, 2) RAS, 3) Primary keratinocytes, 4) Skin inflammation, 5) MyD88, 6) PKC, 7) Cancer Biology, skin carcinogenesis (cutaneous squamous cell carcinoma) following two-stage chemical carcinogenesis (DMBA-TPA), genetically modified mouse models to study pathways contributing to carcinogenesis (PKC, MyD88, CXCR2, EGFR, MET, MTOR).